0001209191-20-054929.txt : 20201015 0001209191-20-054929.hdr.sgml : 20201015 20201015174412 ACCESSION NUMBER: 0001209191-20-054929 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201013 FILED AS OF DATE: 20201015 DATE AS OF CHANGE: 20201015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EHRLICH JASON CENTRAL INDEX KEY: 0001754049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 201242238 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-13 0 0001468748 Kodiak Sciences Inc. KOD 0001754049 EHRLICH JASON 2631 HANOVER STREET PALO ALTO CA 94304 0 1 0 0 See Remarks Common Stock 2020-10-13 4 M 0 5000 10.29 A 47843 D Common Stock 2020-10-13 4 S 0 5000 75.00 D 42843 D Stock Option (Right to Buy) 10.29 2020-10-13 4 M 0 5000 0.00 D 2028-08-29 Common Stock 5000 367575 D The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Chief Medical Officer and Chief Development Officer /s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich 2020-10-15